Warning: fopen(/home/virtual/pediatrics/journal/upload/ip_log/ip_log_2024-05.txt) [function.fopen]: failed to open stream: Permission denied in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 82

Warning: fwrite(): supplied argument is not a valid stream resource in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 83
Final height of patients with congenital heart disease

Korean Journal of Pediatrics 2010;53(2):203-209.
Published online February 15, 2010.
Final height of patients with congenital heart disease
Soon Ju Lee, Young Kuk Cho, Jae Sook Ma
Department of Pediatrics, Chonnam National University Medical School, Chonnam National University Hospital, Gwang-Ju, Korea
선천성 심장질환을 가진 환자의 최종 키
이순주, 조영국, 마재숙
전남대학교 의과대학 소아과학교실
Correspondence: 
Jae Sook Ma, Tel: +82.62-220-6646, Fax: +82.62-222-6103, Email: cardiol@jnu.ac.kr
Abstract
Purpose
: Growth impairment is usually observed in children with congenital heart disease (CHD). Studies on the final height and weight of this population are insufficient. Our aim was to evaluate the final height of children with CHD and to identify the relationship between CHD and growth.
Methods
: We recorded the values of final height and weights of 105 CHD patients (age, <19 years) who visited Chonnam National University Hospital between November 2000 and March 2009, and we reviewed the medical records.
Results
: The mean values of weight and height of male CHD patients were significantly lower than those of the normal subjects. Patients with severe growth impairment (below the third percentile of normal) included 5 males (8.6%) and 4 females (8.5%) with height less than normal and 9 males (15.5%) and 8 females (17.0%) with weight less than normal. The mean growth of the patients in the cyanotic heart disease group was lower than that of normal subjects, but a statistically significant difference was noted in the weights of males. In a comparative study based on the type of CHD, a significant difference was noted in weights of males. Patients with patent ductus arteriosus and those with tetralogy of Fallot had the highest and lowest mean values of weight, respectively.
Conclusion
: Growth impairment was more evident in children with CHD than normal children. Patients should be treated during an optimal time frame. Thus, CHD patients should be treated if follow-up studies indicate growth impairment.
Key Words: Congenital heart disease, Final height, Growth impairment


METRICS Graph View
  • 2,901 View
  • 13 Download